Baystate Wealth Management’s Organon & Co OGN Stock Holding History

Baystate Wealth Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$6.17K	Buy	427 +69	+19%	+$939	﹤0.01%	840
2023 Q3	$6.23K	Sell	358 -21	-6%	-$438	﹤0.01%	657
2023 Q2	$7.9K	Sell	379 -68	-15%	-$1.48K	﹤0.01%	618
2023 Q1	$10.5K	Buy	447 +12	+3%	+$322	﹤0.01%	555
2022 Q4	$12K	Sell	435 -13	-3%	-$332	﹤0.01%	540
2022 Q3	$10K	Sell	448 -50	-10%	-$1.51K	﹤0.01%	544
2022 Q2	$17K	Buy	498 +1	+0.2%	+$35	﹤0.01%	476
2022 Q1	$17K	Buy	497 +4	+0.8%	+$137	﹤0.01%	494
2021 Q4	$15K	Buy	493 +5	+1%	+$163	﹤0.01%	512
2021 Q3	$16K	Buy	488 +23	+5%	+$736	﹤0.01%	470
2021 Q2	$14K	Buy	+465	New	+$15.3K	﹤0.01%	470

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Baystate Wealth Management's OGN Position: Q4 2023 in Review

Baystate Wealth Management increased its Organon & Co (OGN) stake by 19% in Q4 2023, buying an estimated $939 and bringing the position to 427 shares worth $6.17K. The position accounts for ﹤0.01% of the portfolio, ranked #840.

Baystate Wealth Management first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $17K in Q2 2022. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Baystate Wealth Management held 427 shares of Organon & Co worth $6.17K as of Q4 2023.
Baystate Wealth Management bought 69 Organon & Co shares in Q4 2023, an estimated $939.
Organon & Co made up ﹤0.01% of Baystate Wealth Management's portfolio in Q4 2023, its #840 holding.
Baystate Wealth Management first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
Baystate Wealth Management's Organon & Co position peaked at $17K in Q2 2022.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Baystate Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.